Avelo
Making every breath count with breath aerosol diagnostics
Making every breath count with breath aerosol diagnostics
Avelo is a health care startup based in Switzerland. Established in 2020, the company has a clear mission encapsulated in its slogan, "Making every breath count with breath aerosol diagnostics." Avelo has recently secured a grant investment in December 2022 from IMD Startup Competition. Their focus on breath aerosol diagnostics positions them within a niche market with substantial growth potential. Avelo's innovative approach to diagnostic solutions makes them an intriguing investment opportunity for venture capitalists aiming to support disruptive developments in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | Unknown | 1 | IMD Startup Competition | 12 Dec 2022 |
| Seed Round | Fr.2.20M | 4 |
|
20 Sep 2022 |
| Grant | Fr.150.00K | 1 |
|
22 Jun 2022 |
No recent news or press coverage available for Avelo.
We care about your data, and we'd love to use cookies make your experience better.